{"id":5268,"date":"2014-11-26T13:13:14","date_gmt":"2014-11-26T13:13:14","guid":{"rendered":"\/?p=5268"},"modified":"2014-11-26T13:13:20","modified_gmt":"2014-11-26T13:13:20","slug":"cannabis-science-inc-otcmktscbis-takes-another-step-down","status":"publish","type":"post","link":"\/articles\/cannabis-science-inc-otcmktscbis-takes-another-step-down\/","title":{"rendered":"Cannabis Science Inc. (OTCMKTS:CBIS) Takes Another Step Down"},"content":{"rendered":"\n<p style=\"margin-bottom: 0in;\"><img loading=\"lazy\" decoding=\"async\" style=\"float: right;\" src=\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/88\/88632\/cbis.png\" border=\"0\" width=\"442\" height=\"197\" \/>Cannabis Science Inc. (OTCMKTS:<a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=CBIS\">CBIS<\/a>) once more arouse the investor&#8217;s suspicion by delaying its financial report for Q3 2014. When the report did finally hit the web, it immediately became obvious why <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=CBIS\">CBIS<\/a> <\/strong>was reluctant to file it. <\/p>\n<p style=\"margin-bottom: 0in;\">Although said financial report certainly wasn&#8217;t the worst filing that could be found on the OTC Markets data base, it did not paint a pretty picture of <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=CBIS\">CBIS<\/a>&#8216;s <\/strong>affairs and financial standing for investors:<\/p>\n<ul>\n<li style=\"margin-bottom: 0in;\">Cash &#8211; $443 thousand<\/li>\n<li style=\"margin-bottom: 0in;\">Total current assets &#8211; $782 thousand<\/li>\n<li style=\"margin-bottom: 0in;\">Total current liabilities &#8211; $4.1 million<\/li>\n<li style=\"margin-bottom: 0in;\"><span style=\"color: #ff0000;\"><strong>NO REVENUES<\/strong><\/span><\/li>\n<li style=\"margin-bottom: 0in;\">Net Loss &#8211; $675 thousand<\/li>\n<\/ul>\n<p style=\"margin-bottom: 0in;\">Naturally, investors were not impressed by these numbers &ndash; one look at the charts makes their displeasure clear enough. The ticker was headed down on increasing volume.<\/p>\n<p style=\"margin-bottom: 0in;\">Nov. 19 saw <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=CBIS\">CBIS<\/a> <\/strong>manage to stir things up a bit, through the tried and proven tactic of PR promotion. All the company had to do was spew some optimistic statements and mention that cannabis may eventually have a use for treating disease such as HIV, cancer and Ebola and the ticker rose 4.48%.<\/p>\n<p style=\"margin-bottom: 0in;\">Unfortunately for <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=CBIS\">CBIS<\/a>&#8216;s <\/strong>supporters, the ascent didn&#8217;t last in spite of <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=CBIS\">CBIS<\/a>&#8216;s <\/strong>further PR attempts. The company&#8217;s latest press release more or less repeated <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=CBIS\">CBIS<\/a>&#8216;s&nbsp;newest 8-K fling, that announced that the company is to &ldquo;<em>purchase and license two northern California production farms with a combined total of 51 acres and related equipment for cannabis cultivation and new product development<\/em>&rdquo; from Apothecary Genetics Investments LLC.<\/p>\n<p style=\"margin-bottom: 0in;\"><img loading=\"lazy\" decoding=\"async\" style=\"float: left;\" src=\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/88\/88632\/sssssssssssssssssssssssssssss.jpg\" border=\"0\" width=\"292\" height=\"70\" \/>The property is to be acquired for the &ldquo;<em>modest<\/em>&rdquo; price of 14,500,000 shares of <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=CBIS\">CBIS<\/a> <\/strong>restricted common stock and a funding of $150-300 thousand in working capital per calendar quarter starting <em>&ldquo;in the quarter ending December 31, 2014<\/em>&rdquo;.<\/p>\n<p style=\"margin-bottom: 0in;\">Investors were obviously not convinced by the effort, and as a result yesterday <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=CBIS\">CBIS<\/a> <\/strong>lost another 5.22% of its market value and is now stuck at $0.0635.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cannabis Science Inc. (OTCMKTS:CBIS) once more arouse the investor&#8217;s suspicion by delaying its financial report for Q3 2014. When the report did finally hit the web, it immediately became obvious why CBIS was reluctant&#46;&#46;&#46;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[229],"class_list":["post-5268","post","type-post","status-publish","format-standard","hentry","category-news","tag-cbis"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/5268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=5268"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/5268\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=5268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=5268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=5268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}